MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation

Diagnosis and treatment of prostate cancer (PCа) are associated with the serum level of prostate specific antigen (PSA). However, certain prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis can also affect PSA levels. The low specificity and sensitivity of PSA leads to a &qu...

Full description

Saved in:
Bibliographic Details
Main Authors: Z. M. Akhokhov, R. S. Ismailov, M. I. Kogan
Format: Article
Language:Russian
Published: Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education 2023-10-01
Series:Вестник урологии
Subjects:
Online Access:https://www.urovest.ru/jour/article/view/760
Tags: Add Tag
No Tags, Be the first to tag this record!